BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Ischemia
,
Intestine
,
Avian flu virus
,
Cisplatin
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
positive regulation of amyloid-beta clearance
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Vena cava
Aorta
Pericardium
Thyroid gland
Pituitary gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Anthrax
Sepsis due to Escherichia coli
Osteomyelitis
Microbial culture finding
Ebola virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
KIN001-269
Indinavir
Thiamphenicol
Ethacrynic Acid
OTS-167
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR574
PSAT1
VAMP7
SMAD9
AKIRIN2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7.311 cells with CRISPR-induced gene knockouts
L1000 CMAP - Cervical cancer HELA.311 cells with CRISPR induced gene knockouts
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for positive regulation of amyloid-beta clearance
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early…
Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
Nilotinib in Huntington's Disease
Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease
COGNIShunt® System for Alzheimer's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ